Detailed information for compound 776017

Basic information

Technical information
  • TDR Targets ID: 776017
  • Name: 5-(6-bromo-4-oxo-3,1-benzoxazin-2-yl)-2-methy lisoindole-1,3-dione
  • MW: 385.168 | Formula: C17H9BrN2O4
  • H donors: 0 H acceptors: 3 LogP: 2.6 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: Brc1ccc2c(c1)c(=O)oc(n2)c1ccc2c(c1)C(=O)N(C2=O)C
  • InChi: 1S/C17H9BrN2O4/c1-20-15(21)10-4-2-8(6-11(10)16(20)22)14-19-13-5-3-9(18)7-12(13)17(23)24-14/h2-7H,1H3
  • InChiKey: SWOINTZTAGVBAW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-(6-bromo-4-oxo-3,1-benzoxazin-2-yl)-2-methyl-isoindoline-1,3-dione
  • 5-(6-bromo-4-oxo-3,1-benzoxazin-2-yl)-2-methylisoindoline-1,3-dione
  • 5-(6-bromo-4-keto-3,1-benzoxazin-2-yl)-2-methyl-isoindoline-1,3-quinone
  • 5-(6-bromo-4-oxo-3,1-benzoxazin-2-yl)-2-methyl-isoindole-1,3-dione
  • ZINC00692551
  • AN-979/40827094

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Leishmania major alpha glucosidase II subunit, putative 0.0036 0 0.5
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0036 0 0.5
Echinococcus multilocularis voltage dependent L type calcium channel subunit 0.0075 0.318 0.318
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0073 0.2998 0.2998
Trichomonas vaginalis neutral alpha-glucosidase ab precursor, putative 0.0036 0 0.5
Echinococcus multilocularis voltage dependent calcium channel 0.0075 0.318 0.318
Echinococcus multilocularis voltage dependent calcium channel type d subunit 0.0075 0.318 0.318
Trypanosoma brucei glucosidase, putative 0.0036 0 0.5
Loa Loa (eye worm) calcium channel 0.0075 0.318 0.318
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0161 1 1
Echinococcus multilocularis fetal alzheimer antigen, falz 0.0046 0.0819 0.0819
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0036 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0078 0.3395 0.3395
Schistosoma mansoni alpha-glucosidase 0.0138 0.821 1
Echinococcus multilocularis voltage dependent calcium channel 0.0075 0.318 0.318
Schistosoma mansoni hypothetical protein 0.0042 0.0508 0.0618
Entamoeba histolytica glycosyl hydrolase, family 31 protein 0.0036 0 0.5
Brugia malayi Bromodomain containing protein 0.0153 0.9359 0.9359
Trichomonas vaginalis sucrase-isomaltase, putative 0.0036 0 0.5
Loa Loa (eye worm) PHD-finger family protein 0.0042 0.0508 0.0508
Schistosoma mansoni high voltage-activated calcium channel Cav1 0.0075 0.318 0.3874
Echinococcus multilocularis lysosomal alpha glucosidase 0.0161 1 1
Echinococcus multilocularis voltage dependent calcium channel type d subunit 0.0075 0.318 0.318
Schistosoma mansoni voltage-gated cation channel 0.0075 0.318 0.3874
Echinococcus multilocularis voltage dependent L type calcium channel subunit 0.0075 0.318 0.318
Brugia malayi Voltage-gated calcium channel, L-type, alpha subunit. C. elegans egl-19 ortholog 0.0075 0.318 0.318
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0121 0.6868 0.6868
Onchocerca volvulus 0.0093 0.4581 0.5
Echinococcus multilocularis lysosomal alpha glucosidase 0.0161 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Toxoplasma gondii glycosyl hydrolase, family 31 protein 0.0036 0 0.5
Brugia malayi PHD-finger family protein 0.0051 0.1204 0.1204
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Brugia malayi Bromodomain containing protein 0.0078 0.3384 0.3384
Trichomonas vaginalis alpha-glucosidase, putative 0.0036 0 0.5
Schistosoma mansoni zinc finger protein 0.004 0.0335 0.0409
Schistosoma mansoni bromodomain containing protein 0.0129 0.7451 0.9075
Schistosoma mansoni alpha-glucosidase 0.0138 0.821 1
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel alpha 1 0.0075 0.318 0.318
Echinococcus multilocularis zinc finger protein 0.004 0.0335 0.0335
Schistosoma mansoni high voltage-activated calcium channel Cav2A 0.0075 0.318 0.3874
Loa Loa (eye worm) hypothetical protein 0.0087 0.4092 0.4092
Echinococcus granulosus zinc finger protein 0.004 0.0335 0.0335
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0073 0.2998 0.2998
Schistosoma mansoni acetyl-CoA C-acetyltransferase 0.0046 0.0819 0.0997
Trichomonas vaginalis maltase-glucoamylase, putative 0.0036 0 0.5
Echinococcus granulosus voltage dependent L type calcium channel subunit|voltage dependent calcium channel 0.0075 0.318 0.318
Trichomonas vaginalis alpha-glucosidase, putative 0.0036 0 0.5
Echinococcus granulosus fetal alzheimer antigen falz 0.0046 0.0819 0.0819
Loa Loa (eye worm) hypothetical protein 0.0075 0.318 0.318
Echinococcus granulosus lysosomal alpha glucosidase 0.0161 1 1
Loa Loa (eye worm) hypothetical protein 0.0144 0.8663 0.8663
Trichomonas vaginalis alpha-glucosidase, putative 0.0036 0 0.5
Echinococcus granulosus voltage dependent calcium channel 0.0075 0.318 0.318
Trichomonas vaginalis alpha-glucosidase, putative 0.0036 0 0.5
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0121 0.6868 0.6868
Loa Loa (eye worm) bromodomain containing protein 0.0036 0.0024 0.0024
Trichomonas vaginalis alpha-glucosidase, putative 0.0036 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0083 0.3781 0.3781
Echinococcus granulosus voltage dependent calcium channel type d subunit|voltage dependent calcium channel|voltage dependent L type calcium channel subu 0.0075 0.318 0.318

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.